Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 99,800 shares at $75.19 ($7.6M) on 2019-02-01, disclosed to the SEC on 2019-02-05.
Seasonal sale ($7.6M) by Chief Scientific Officer — this insider has traded GHDX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.19 | 5,340 | $402K | 5.3% |
| 2 | $75.19 | 5,340 | $402K | 5.3% |
| 3 | $76.03 | 19,460 | $1.5M | 19.4% |
| 4 | $76.03 | 19,460 | $1.5M | 19.4% |
| 5 | $76.61 | 200 | $15K | 0.2% |
| 6 | $75.70 | 2,192 |
| $166K |
| 2.2% |
| 7 | $75.70 | 2,192 | $166K | 2.2% |
| 8 | $76.72 | 19,080 | $1.5M | 19.2% |
| 9 | $76.72 | 19,080 | $1.5M | 19.2% |
| 10 | $77.40 | 3,728 | $289K | 3.8% |
| 11 | $77.40 | 3,728 | $289K | 3.8% |
| Total | $76.29 avg | 99,800 | $7.6M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |